Abstract:According to the World Health Organization, the number of people infected with COVID-19 continues to increase globally, highlighting the urgent need for effective treatments. Research has shown that certain antibodies targeting the envelope (E) protein of the virus can prevent viral entry. This study aimed to investigate the ion transport process mechanism in the E protein of COVID-19 and to identify potential inhibitors using virtual screening. The study utilized molecular docking and molecular dynamics simulations to understand the ion transport mechanism and proposed possible inhibitors that can bind strongly to the opening of the ion channel. The simulations revealed significant conformational changes during the ion transport process. These findings demonstrate the potential of simulation techniques for understanding the structural dynamics in developing inhibitors that can bind to the E protein of COVID-19.

What problem does this paper attempt to address?

This paper aims to explore the mechanism of the ion - transport process in the SARS - CoV - 2 virus envelope protein (E protein) and identify potential inhibitors through virtual screening methods. Specifically, the study utilized molecular docking and molecular dynamics simulation techniques to understand the ion - transport mechanism and proposed possible inhibitors that can strongly bind to the opening of the ion channel. These findings demonstrate the potential of simulation techniques in developing inhibitors that can bind to the E protein of SARS - CoV - 2. ### Main research questions: 1. **Ion - transport mechanism**: Study how ions in the envelope protein move from one position to another, especially the conformational changes under different pH conditions. 2. **Identification of potential inhibitors**: Through virtual screening and molecular dynamics simulation, look for compounds that can effectively bind to and inhibit the function of the E protein. ### Research background: - **Global impact**: The COVID - 19 pandemic has had a significant impact on global health, society, and the economy. - **Importance of E protein**: The E protein is one of the four structural proteins of the SARS - CoV - 2 virus, participating in virus assembly and release, and is an important target for antiviral treatment and vaccine development. - **Membrane proteins as drug targets**: Membrane proteins play a crucial role in cellular processes and thus become important targets for drug development. ### Research methods: - **Molecular docking**: Use Autodock Vina software to explore the binding poses of ligands at the opening of the E protein. - **Molecular dynamics simulation**: Use GROMACS software and AMBER03 force field to perform a 200 - nanosecond simulation to analyze the structural dynamics of the E protein and potential drug - binding sites. ### Main findings: - **Conformational changes**: Simulation results show that during the 200 - nanosecond molecular dynamics simulation, the five α - helical domains of the E protein were significantly distorted, causing the E8 and N15 residues to move outward, thereby enlarging the pore size of the ion channel. - **Ion - transport mechanism**: Under acidic conditions, specific residues such as F20, F23, and F26 move outward, causing the distortion of the α - helical domains, which in turn causes the E8 and N15 residues to move outward and open the ion channel. - **Potential inhibitors**: Through molecular docking and molecular dynamics simulation, five inhibitors that can strongly bind to the opening of the ion channel were proposed. ### Conclusion: This study explored in detail the ion - transport mechanism of the E protein of the SARS - CoV - 2 virus through molecular dynamics simulation and proposed several potential inhibitors. These findings not only help to understand the function of the E protein but also provide a new direction for the development of therapeutic drugs for COVID - 19.

Exploring the Mechanism of the Envelope Protein of SARS-CoV-2: A Molecular Dynamics Study

Structure-based Virtual Screening, in Silico Docking, ADME Properties Prediction and Molecular Dynamics Studies for the Identification of Potential Inhibitors Against SARS-CoV-2 Mpro.

A Search for Medications to Treat COVID-19 Via in Silico Molecular Docking Models of the SARS-CoV-2 Spike Glycoprotein and 3CL Protease

REVISITING THE SARS-COV-2 MAIN PROTEASE: A 2023 IN SILICO ODYSSEY IN SEARCH OF POTENTIAL INHIBITORS

Interactive Mechanism of Potential Inhibitors with Glycosyl for SARS-CoV-2 by Molecular Dynamics Simulation

Computational investigation of potential inhibitors of novel coronavirus 2019 through structure-based virtual screening, molecular dynamics and density functional theory studies

Systematic virtual screening in search of SARS CoV-2 inhibitors against spike glycoprotein: pharmacophore screening, molecular docking, ADMET analysis and MD simulations

Exploring the Efficacy of Noncovalent SARS-CoV-2 Main Protease Inhibitors: A Computational Simulation Analysis Study.

The Study of the Binding Ability of Antimicrobial Peptides to Spike Protein of the Coronavirus by Docking and Molecular Dynamics Simulation

In silico virtual screening, characterization, docking and molecular dynamics studies of crucial SARS-CoV-2 proteins

Targeting Receptor Binding Domain and Cryptic Pocket of Spike glycoprotein from SARS-CoV-2 by biomolecular modeling

Conformational dynamics and allosteric modulation of the SARS-CoV-2 spike

Electrophysiological properties and structural prediction of the SARS-CoV-2 viroprotein E

Structural stability predictions and molecular dynamics simulations of RBD and HR1 mutations associated with SARS-CoV-2 spike glycoprotein

Exploring the Regulatory Function of the N-terminal Domain of SARS-CoV-2 Spike Protein Through Molecular Dynamics Simulation

Identification of possible SARS-CoV-2 main protease inhibitors: in silico molecular docking and dynamic simulation studies

Molecular Docking and Dynamics Studies to Explore Effective Inhibitory Peptides Against the Spike Receptor Binding Domain of SARS-CoV-2

Receptor-Based Pharmacophore Modelling of a series of ligands used as inhibitors of the SARS-CoV-2 virus by complementary theoretical approaches, molecular docking, and reactivity descriptors.

Screening, simulation, and optimization design of small molecule inhibitors of the SARS-CoV-2 spike glycoprotein

A detailed study of ion transport through the SARS-CoV-2 E protein ion channel

Pharmacophore based virtual screening, molecular docking, molecular dynamics and MM-GBSA approach for identification of prospective SARS-CoV-2 inhibitor from natural product databases